Excitatory amino acid inhibitors for treating sensitive skins

Details Excitatory amino acid inhibitors for treating sensitive skins Excitatory amino acid inhibitors for treating sensitive skins

2003-03-31

2009-10-13

Wang, Shengjun (Department: 1617)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

C514S120000, C514S223800, C514S367000, C514S423000

Reexamination Certificate

active

07601360

ABSTRACT:
Sensitive human skin/scalp/mucous membrane conditions, for example skin irritation and/or dry patches and/or erythemas and/or dysaesthesic sensations and/or sensations of heating and/or pruritus, are therapeutically treated by topically applying thereto an effective condition-alleviating amount of at least one inhibitor of at least one excitatory amino acid.

REFERENCES:
patent: 5455042 (1995-10-01), Sakai et al.
patent: 5607980 (1997-03-01), McAtee et al.
patent: 5679360 (1997-10-01), de Lacharriere et al.
patent: 5817699 (1998-10-01), Flores et al.
patent: 6190691 (2001-02-01), Mak
patent: 6203803 (2001-03-01), de Lacharriere et al.
patent: 6616933 (2003-09-01), Breton et al.
patent: 0529636 (1993-03-01), None
patent: 0680749 (1995-11-01), None
patent: 0691126 (1996-01-01), None
patent: 0717997 (1996-06-01), None
patent: 92/17168 (1992-10-01), None
patent: 97/10815 (1997-03-01), None
Xu et al. “Systemic excitatory amino acid receptor antagonists of teh alpha-amino-3-hydroxy-5-methyl-4-isooxazolepropionic acid (AMPA) receptor and the N-methyl-D-aspartate (NMDA) receptor relievemechanical hypersensitivity after transient spinal cod ischemia in rats,” Journal of Pharmacology and Experimental Therapeutics, 1993, 267(1), 140-4.
Johansen et al. “Interactions among GYKI-52466, cyclothiazide, ānd aniracetam at recombinant AMPA and Kainnate receptors,” Molecular Pharmacology, 1995, vol. 48, No. 5, pp. 946-955.
Chen et al. “Contemporary Management of Neuropathic Pain for the primary care physician,” Mayo Clin. Proc. 2004, vol. 79, No. 12,, pp. 1533-1545.
Smullin et al, Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord,Pain, vol. 42, pp. 93-101 (1990), published by Elsevier Science Publishers B.V., Amsterdam.
Chemical Abstracts, vol. 122, No. 19, p. 93, May 8, 1995, Abstract No. 230656k, published by American Chemical Society, Columbus, Ohio.
Chemical Abstracts, vol. 119, No. 3, p. 75, Jul. 19, 1993, Abstract No. 20398q, published by American Chemical Society, Columbus, Ohio.
“Excitatory Amino Acid Uptake Inhibitors”, http://www.komabiotech.co.kr/product
euro/category/Excitatory—Amino—Acid.htm, Apr. 4, 2006.
Mennini et al., “Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerations”, European Journal of Pharmacology 479 (2003) 291-296, Elsevier B.V., The Netherlands.
Dana Giulian et al., “Study of Receptor-Mediated Neurotoxins Released by HIV-1-Infected Mononuclear Phagocytes Found in Human Brain”, The Journal of Neuroscience, May 15, 1996, 16(10): 3139-3153, The Society for Neuroscience, Washington, DC.
Bong et al., “Spinal Cord Adenosine Receptor Stimulation in Rats Inhibits Peripheral Neutrophil Accumulation”, J. Clin. Invest., vol. 98, No. 12, 2779-2785, 1996, American Society for Clinical Investigation Inc., United States.

Affiliated with

Also associated with

Rating

Excitatory amino acid inhibitors for treating sensitive skins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Excitatory amino acid inhibitors for treating sensitive skins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Excitatory amino acid inhibitors for treating sensitive skins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4069158